Syntax, a leading global technology solutions provider driving enterprise transformation in the cloud, today announced it has received a Golden Certificate from SAP® in recognition of 10 consecutive ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), ...

AI is changing what employers want from tech workers, but demand remains strong, according to an analysis of 2.85 million job ...

Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.

A local stem cell therapy company added several new investors as part of its Series A expansion. Learn more here.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...

A five-character fix turned a failing Lighthouse Agentic Browsing audit into a clean pass. What that reveals about what the audit actually measures.

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), a leader in induced pluripotent stem cell (iPSC) technology and genome ...

After betting on AI, Ford reversed course and rehired hundreds of engineers. Here’s what every company got wrong about ...